Triamcinolone Acetonide Injection, Suspension
Product Images NDC 25021-054

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Triamcinolone Acetonide (NDC 25021-054). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Tri0u 0000 01)

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Tri0u 0000 02)

Package Label – Principal Display Panel – Vial Label (Tri0u 0000 02)
This is a product information for a medication with the code No. GUJ/DRUGS/G/28/1704. The medication is identified as Reonty with active ingredient Triamcinolone Acetonide Injectable Suspension. It contains 40 mg per mL and is intended for Intramuscular or Intra-articular use only. The medication is not suitable for IV, ID, intraocular, epidural, or intrathecal use. It is manufactured for SAGENT Pharmaceuticals and made in India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.